Could a simple diet beat metabolic syndrome? genes may hold the key

NCT ID NCT06978504

Completed Disease control Sponsor: Nutrindo Ideais Research Center Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study tests whether a DASH diet—a plan rich in fruits, vegetables, and low-fat dairy—can help menopausal women with metabolic syndrome lose weight and improve health markers like blood pressure, cholesterol, and blood sugar. Researchers will also check if certain gene variations affect how well the diet works. The study follows 30 women aged 40 to 60 for 90 days, with regular check-ins and blood tests to track progress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DASH diet
What this could lead to: If successful, this could show that a DASH diet helps menopausal women with metabolic syndrome lose weight and improve blood pressure, cholesterol, and blood sugar, potentially offering a simple lifestyle approach to managing this condition.
What could go wrong: This is a small, early study with only 30 participants and no comparison group, so results may not apply to all women. The diet's effects may also vary based on genetics, and long-term benefits are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC POLYMORPHISMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome metabolic syndrome X nutritional disorder Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENETIC POLYMORPHISMS METABOLIC SYNDROME NUTRITION OBESITY WEIGHT LOSS

Contacts and locations

Locations

Nutrindo Ideais Research Center

Rio de Janeiro, Rio de Janeiro, 22421-000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.